Miguel Chenlo

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Nature communications

Cancers

Pharmaceutics

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) - University of Santiago de Compostela

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) - University of Santiago de Compostela Feb 01 2016

Spain

PhD Student :: Neoplasia and endocrine differentiation

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela Dec 01 2016 - Jun 30 2017

Spain

Research assistant :: Neoplasia and endocrine differentiation

Publications

Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joanne Heade, Fiona McCartney, Miguel Chenlo, Olga Moreno Marro, Maja Severic, Robert Kent, Sinead B Bleiel, Clara V Alvarez, Brendan T Griffin, David J Brayden
Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System. Pharmaceutics 13 (5) (2021)
Miguel Chenlo, Elvin Aliyev, Joana S Rodrigues, Paula Vieiro-Balo, Manuel N Blanco Freire, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers. Cancers 12 (12) (2020)

Miguel Chenlo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel Chenlo